Overview

The Bioequivalence Study of Acyclovir 800 mg Tablet in Healthy Thai Volunteers Under Fasting Conditions

Status:
NOT_YET_RECRUITING
Trial end date:
2024-02-22
Target enrollment:
Participant gender:
Summary
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Acyclovir 800 mg Tablet and Reference Product (Zovirax™) in Healthy Thai Volunteers under Fasting Conditions
Phase:
PHASE1
Details
Lead Sponsor:
International Bio service
Treatments:
Acyclovir
Tablets